|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 248.70 EUR | -2.01% |
|
-3.57% | +4.23% |
| 07-03 | Berenberg Updates Price Target, Estimates for UCB on Recent Pipeline Deals | MT |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 274.9 | 285.4 | 279.5 |
| Spread/Res. | -9.53% | -12.86% | -11.02% |
| Spread/Supp. | +0.44% | +9.95% | +34.80% |
| Support | 247.6 | 226.2 | 184.5 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
